A consensus protocol for the standardization of cerebrospinal fluid collection and biobanking.
about
Proteomic profiling in multiple sclerosis clinical courses reveals potential biomarkers of neurodegenerationPreanalytical Confounding Factors in the Analysis of Cerebrospinal Fluid Biomarkers for Alzheimer's Disease: The Issue of Diurnal VariationProteomics and systems biology: current and future applications in the nutritional sciencesQuantitative detection of amyloid-β peptides by mass spectrometry: state of the art and clinical applicationsBiomarkers of therapeutic response in multiple sclerosis: current statusEffects of blood contamination and the rostro-caudal gradient on the human cerebrospinal fluid proteomeThe Swiss Multiple Sclerosis Cohort-Study (SMSC): A Prospective Swiss Wide Investigation of Key Phases in Disease Evolution and New Treatment OptionsGlutaminyl cyclase activity correlates with levels of Aβ peptides and mediators of angiogenesis in cerebrospinal fluid of Alzheimer's disease patients.Clinical, MRI, and CSF markers of disability progression in multiple sclerosis.Microscopic particles in two fractions of fresh cerebrospinal fluid in twins with schizophrenia or bipolar disorder and in healthy controls.CSF-PR 2.0: An Interactive Literature Guide to Quantitative Cerebrospinal Fluid Mass Spectrometry Data from Neurodegenerative Disorders.Characterization of the spectrum of Korean inflammatory demyelinating diseases according to the diagnostic criteria and AQP4-Ab statusThe chemokine CXCL13 is a prognostic marker in clinically isolated syndrome (CIS).Soluble CD163 as a marker of macrophage activity in newly diagnosed patients with multiple sclerosis.Nutrients required for phospholipid synthesis are lower in blood and cerebrospinal fluid in mild cognitive impairment and Alzheimer's disease dementia.The association of angiotensin-converting enzyme with biomarkers for Alzheimer's diseaseDirectional information flow in patients with Alzheimer's disease. A source-space resting-state MEG study.Identification of biomarkers for diagnosis and progression of MS by MALDI-TOF mass spectrometry.Blood and CSF Biomarker Dynamics in Multiple Sclerosis: Implications for Data Interpretation.Standardizing the structure of stroke clinical and epidemiologic research data: the National Institute of Neurological Disorders and Stroke (NINDS) Stroke Common Data Element (CDE) project.cNEUPRO: Novel Biomarkers for Neurodegenerative Diseases.Standardization of Assay Procedures for Analysis of the CSF Biomarkers Amyloid β((1-42)), Tau, and Phosphorylated Tau in Alzheimer's Disease: Report of an International Workshop.Identifying and validating biomarkers for Alzheimer's disease.Circulating miR-150 in CSF is a novel candidate biomarker for multiple sclerosisWhat makes a prognostic biomarker in CNS diseases: strategies for targeted biomarker discovery? Part 1: acute and monophasic diseases.Cerebrospinal fluid lysosomal enzymes and alpha-synuclein in Parkinson's diseaseCerebrospinal fluid immunoglobulin kappa light chain in clinically isolated syndrome and multiple sclerosis.A highly sensitive novel immunoassay specifically detects low levels of soluble Aβ oligomers in human cerebrospinal fluid.A consensus in Korea regarding a protocol to reduce preanalytical sources of variability in the measurement of the cerebrospinal fluid biomarkers of Alzheimer's disease.Biomarkers of inflammation and axonal degeneration/damage in patients with newly diagnosed multiple sclerosis: contributions of the soluble CD163 CSF/serum ratio to a biomarker panel.Consensus Guidelines for CSF and Blood Biobanking for CNS Biomarker Studies.Plasma neurofilament heavy chain levels and disease progression in amyotrophic lateral sclerosis: insights from a longitudinal study.Vitamin D Binding Protein Isoforms and Apolipoprotein E in Cerebrospinal Fluid as Prognostic Biomarkers of Multiple Sclerosis.Neurofilament light chain: A prognostic biomarker in amyotrophic lateral sclerosis.The intrathecal, polyspecific antiviral immune response in neurosarcoidosis, acute disseminated encephalomyelitis and autoimmune encephalitis compared to multiple sclerosis in a tertiary hospital cohort.Analysis of the Cerebrospinal Fluid Proteome in Alzheimer's Disease.Gray matter-related proteins are associated with childhood-onset multiple sclerosisCXCL13 is the major determinant for B cell recruitment to the CSF during neuroinflammation.The Central Biobank and Virtual Biobank of BIOMARKAPD: A Resource for Studies on Neurodegenerative Diseases.Antibodies to MOG in adults with inflammatory demyelinating disease of the CNS.
P2860
Q21131975-54DDCE5E-5647-4D7D-AF5F-46D6903F7710Q26801663-581368C6-F54E-403B-901F-E139FBB251CEQ26829598-F008075A-CC98-494D-BBE6-0EBC11FE124DQ26995267-AF6861B3-A25D-46CE-AB14-0EE8C7545275Q27012726-C6613D2E-F5DC-4529-8AA3-BB7519C40AD8Q28540483-CEAFE132-2680-4536-9662-6E5E5ADFAF0AQ28601505-8A67FD86-F1EE-4B81-86BB-F81F8650EF16Q30313120-01036DB0-1277-4DE9-B8C6-539ED7CF18F4Q30712257-8D6C7BCE-0827-4011-A899-7EB09332D5C4Q31103307-907D5834-B66C-43EE-98A4-A23E621F175DQ31144959-FC8C69E9-3B34-4D46-9095-56B197EDFF0FQ33646430-1333864A-414A-4121-AFD8-D4C33F63986FQ33654152-3C9773B1-6E96-4193-ADB0-40BAD811AF8FQ33700473-A1912091-FD50-4AC8-B037-B9FF1DB6F9AFQ33813927-4B64371F-049F-4F3B-BAE1-D9754A2AE528Q33821846-3B885F40-D57D-4D8F-9DE4-703AABEC2FEEQ33840101-BAB6A0FB-E91A-4FB2-97C2-59168EBA8A31Q33877162-1D99B310-2DF7-43A8-B5FA-B5B991B91340Q34078026-CF40E9E8-8C09-4B91-826F-EE5D12F3AE48Q34151647-EEBACC3A-D1ED-496A-AD71-6E290A840A8CQ34155662-123E5250-F4B2-48FD-909E-F9628B5108BAQ34169857-5A79F595-79A4-4BC1-BE60-A99F038F6153Q34468961-B8667307-82AC-43FB-9F19-2C6E5F11FBA6Q34524908-0C6C2E22-D317-4515-B63C-14A8DD328C50Q34619162-1EB943E9-99AF-4C5C-8013-2FF8A8732EF8Q34806122-10FE01FF-1454-4E4E-A6FE-CE461C62BC4DQ35138419-53BD979A-84CA-459C-959D-1DD076D23D27Q35206591-5F86D04E-0F86-4B41-9FEE-3B9BAA1A11A6Q35291150-F138B73E-C93C-4508-945F-5C183A2EFBEDQ35364112-118B968F-F538-4969-88ED-0DCEFE6F34CFQ35377133-F331F9B4-E8FC-46A2-A041-28F738D77139Q35550715-0487B213-D238-449C-A06F-CA4FEEF9047FQ35653715-A05DFFDC-36AD-4D52-ABB1-503BD55B2792Q35686186-98FAF29D-003D-4CF0-8303-B0B2DCC446C0Q35864847-2BCE05E9-60A9-454E-BA96-82C4F07C153DQ35948036-797DDD97-A53A-43E6-8119-1291CAF11425Q36092695-903F3F41-A10E-49D2-B48D-83E3A34104B4Q36161486-46E6BDD9-099F-4055-A9EB-3197CCB11CB1Q36162523-7F62CD2F-EA8B-45EA-8488-98F5400C93ABQ36170912-B27ACA9E-C6B9-4149-8E59-3E6820A62946
P2860
A consensus protocol for the standardization of cerebrospinal fluid collection and biobanking.
description
2009 nî lūn-bûn
@nan
2009 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
A consensus protocol for the s ...... uid collection and biobanking.
@ast
A consensus protocol for the s ...... uid collection and biobanking.
@en
type
label
A consensus protocol for the s ...... uid collection and biobanking.
@ast
A consensus protocol for the s ...... uid collection and biobanking.
@en
prefLabel
A consensus protocol for the s ...... uid collection and biobanking.
@ast
A consensus protocol for the s ...... uid collection and biobanking.
@en
P2093
P2860
P50
P1433
P1476
A consensus protocol for the s ...... luid collection and biobanking
@en
P2093
C E Teunissen
D Franciotta
F Deisenhammer
F S Berven
G Giovannoni
H K Schmidt
P2860
P304
P356
10.1212/WNL.0B013E3181C47CC2
P407
P577
2009-12-01T00:00:00Z